2010
DOI: 10.3109/02713683.2010.481068
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological Modification of the Epithelial Permeability by Benzalkonium Chloride in UVA/Riboflavin Corneal Collagen Cross-Linking

Abstract: Treatment with BAC 0.02% induces sufficient epithelial permeability for the passage of riboflavin, which enables its stromal diffusion and results in increased corneal stiffening after cross-linking as compared to the standard protocol. Further safety studies will be required before clinical use.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
66
0
3

Year Published

2011
2011
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 93 publications
(71 citation statements)
references
References 34 publications
2
66
0
3
Order By: Relevance
“…However, this can cause postoperative discomfort and infectious keratitis. Alternative methods to deliver riboflavin have been tested, including using femtosecond laser-created pockets or through intact epithelium [176]. Chan et al demonstrated the effectiveness of riboflavin/UVA induced CXL on patients whose eyes had their epithelium left intact.…”
Section: Riboflavin-based Bioadhesivementioning
confidence: 99%
“…However, this can cause postoperative discomfort and infectious keratitis. Alternative methods to deliver riboflavin have been tested, including using femtosecond laser-created pockets or through intact epithelium [176]. Chan et al demonstrated the effectiveness of riboflavin/UVA induced CXL on patients whose eyes had their epithelium left intact.…”
Section: Riboflavin-based Bioadhesivementioning
confidence: 99%
“…Various transepithelial agents such as benzalkonium chloride, surfactants (TRIS), ethylenediaminetetraacetic acid (EDTA), and topical anesthetics have been shown to weaken the epithelial cell junctions, thus increasing penetration. [11][12][13][14] Clinically, the most widely used transepithelial CXL agent is riboflavin-dextran solution supplemented with TRIS-hydroxymethyl aminomethane and sodium EDTA (Ricrolin TEe; Sooft, Montegiorgio, Italy) that acts as permeabilizing/ carriers for the polymerizing agent. 13,14 Filippello and coworkers 15 have clinically demonstrated the ability of Ricrolin TE transepithelial CXL to halt the progression of keratoconus for up to 18 months with improvement in visual acuity and topographic measurements.…”
Section: Introductionmentioning
confidence: 99%
“…A. Kissner и соавт. ставят в прямую зависимость эффективность кросслинкинга от качества стромального насыщения рибофлавином, которое зависит от целост-ности эпителия или присутствия в растворе пенетраторов, облегчающих трансэпителиальную диффузию фотосен-сибилизатора [58]. Транспорт рибофлавина через корне-альный эпителий можно осуществлять с использованием бензалкония хлорида, входящего, в частности, в состав ряда глазных капель в качестве консерванта.…”
Section: трансэпителиальный уф-кросслинкингunclassified